Genelux (GNLX) Other financing activities (2023 - 2026)
Genelux (GNLX) posted Other financing activities of $13000.0 for Q1 2026, down 93.81% on a QoQ basis from $210000.0 in Q4 2025, and down 7.14% year-over-year from $14000.0 in Q1 2025.
Analysis
Genelux (GNLX) Other financing activities (2023 - 2026) Analysis & Trends
Genelux has reported Other financing activities for 4 years, with the latest figure at $13000.0 in Q1 2026.
- On a quarterly basis, Other financing activities fell 7.14% year-over-year to $13000.0 in Q1 2026; TTM through Mar 2026 was $223000.0, a 1492.86% increase from a year earlier, with the FY2025 full-year figure at $224000.0, down 67.44% from the prior year.
- Other financing activities was $13000.0 for Q1 2026 at Genelux, down from $210000.0 in the prior quarter.
- The five-year high for Other financing activities was $14.5 million in Q1 2023, with the low at $1321.0 in Q3 2023.
- Average Other financing activities over 4 years is $2.6 million, with a median of $112000.0 recorded in 2025.
- The sharpest annual moves came in 2025 and 2026: Other financing activities tumbled 97.97% in 2025, then decreased 7.14% in 2026.
- Over 4 years, Other financing activities stood at $1321.0 in 2023, then soared by 51981.76% to $688000.0 in 2024, then plunged by 69.48% to $210000.0 in 2025, then tumbled by 93.81% to $13000.0 in 2026.
- The last three Other financing activities figures came in at $13000.0 (Q1 2026), $210000.0 (Q4 2025), and $14000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Genelux | 108.17 Mn | 108.17 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 13,000.00 |
| Dec 31, 2025 | 210,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Mar 31, 2024 | 688,000.00 |
| Sep 30, 2023 | 1,321.00 |
| Mar 31, 2023 | 14.50 Mn |